博利康尼联合沐舒坦雾化吸入治疗对老年慢性阻塞性肺炎患者炎症与免疫功能的影响研究

Study on the effect of Bricanyl and Mucosolvan aerosol inhalation on inflammation and immune function of elderly patients with chronic obstructive pulmonary

目的:观察博利康尼联合沐舒坦雾化吸入治疗老年慢性阻塞性肺炎的临床疗效,并分析对患者免疫功能的影响。方法:收治老年慢性阻塞性肺炎患者106例,平分两组。对照组患者采用沐舒坦雾化吸入治疗,治疗组患者采用沐舒坦联合博利康尼雾化吸入治疗,观察两组治疗前后免疫功能及炎症相关指标变化情况。结果:治疗组炎性因子改善情况明显优于对照组,两组比较,差异有统计学意义(P<0.05);治疗组免疫功能改善情况明显优于对照组,两组比较,差异有统计学意义(P<0.05)。结论:临床治疗老年慢性阻塞性肺炎应用博利康尼联合沐舒坦雾化吸入疗效显著,同时可提高患者免疫功能。

Objective:To observe the clinical curative effect of bricanyl and mucosolvan aerosol inhalation in the treatment ofsenile chronic obstructive pneumonia,and analyze its influence on immune function.Methods:106cases of hospitalized elderlypatients with chronic obstructive pneumonia were divided into the two groups.The control group were treated with ambroxolinhalation therapy.The patients in the treatment group were treated by inhalation of ambroxol combined with terbutalineatomization.We observed the changes of immune function and inflammation related indicators of patients before and aftertreatment.Results:The treatment group of inflammatory factors improved significantly better than the control group,and thedifference was statistically significant between groups(P<0.05).The immune function improvement in treatment group wassignificantly better than the control group,and the difference was statistically significant(P<0.05).Conclusion:The curative effectof Bbricanyl and mucosolvan aerosol inhalation in the treatment of elderly patients with chronic obstructive pneumonia is obvious,and it can improve the immune function of patients.